These SCFAs can exhibit anti-inflammatory effects by activating free fatty acid receptors, such as G protein-coupled receptors 41 and 43 (GPR41 and GPR43), in patients with asthma and animal models of asthma (Halnes et al., 2017). The gene discussed is FFAR3; the disease is asthma.